CALIÒ, Anna
 Distribuzione geografica
Continente #
NA - Nord America 4.919
EU - Europa 4.818
AS - Asia 3.740
SA - Sud America 683
AF - Africa 148
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 2
Totale 14.326
Nazione #
US - Stati Uniti d'America 4.794
RU - Federazione Russa 2.057
SG - Singapore 1.503
CN - Cina 986
GB - Regno Unito 857
IT - Italia 561
BR - Brasile 541
HK - Hong Kong 387
VN - Vietnam 378
SE - Svezia 263
DE - Germania 259
IE - Irlanda 221
FR - Francia 208
FI - Finlandia 120
KR - Corea 117
IN - India 71
CA - Canada 70
AR - Argentina 60
JP - Giappone 51
UA - Ucraina 51
NL - Olanda 41
MX - Messico 35
ID - Indonesia 33
BD - Bangladesh 31
IQ - Iraq 31
NG - Nigeria 29
PL - Polonia 28
ES - Italia 27
TR - Turchia 27
BE - Belgio 26
BJ - Benin 24
EC - Ecuador 22
TG - Togo 21
ZA - Sudafrica 19
AT - Austria 17
SA - Arabia Saudita 17
VE - Venezuela 17
CO - Colombia 16
MA - Marocco 14
LT - Lituania 13
AU - Australia 12
CH - Svizzera 11
PK - Pakistan 11
TN - Tunisia 11
PY - Paraguay 9
UZ - Uzbekistan 9
EG - Egitto 8
CL - Cile 7
IR - Iran 7
LB - Libano 7
PH - Filippine 7
CZ - Repubblica Ceca 6
DK - Danimarca 6
IL - Israele 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
AZ - Azerbaigian 5
BG - Bulgaria 5
JO - Giordania 5
KZ - Kazakistan 5
MY - Malesia 5
GR - Grecia 4
JM - Giamaica 4
NP - Nepal 4
PS - Palestinian Territory 4
RO - Romania 4
TW - Taiwan 4
BH - Bahrain 3
BO - Bolivia 3
CR - Costa Rica 3
DZ - Algeria 3
HN - Honduras 3
HR - Croazia 3
KE - Kenya 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
OM - Oman 3
PA - Panama 3
PE - Perù 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
AO - Angola 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CM - Camerun 2
CY - Cipro 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
LY - Libia 2
SI - Slovenia 2
SN - Senegal 2
TH - Thailandia 2
AI - Anguilla 1
AM - Armenia 1
BN - Brunei Darussalam 1
Totale 14.298
Città #
Singapore 798
Ashburn 692
Southend 688
Moscow 661
Dallas 624
San Jose 566
Chandler 416
Hong Kong 372
Dublin 219
Verona 214
Beijing 189
The Dalles 189
Woodbridge 159
Jacksonville 150
Ann Arbor 138
Ho Chi Minh City 108
Los Angeles 107
New York 97
Munich 87
Hanoi 81
Council Bluffs 70
Lawrence 68
Princeton 68
Wilmington 67
Houston 65
Jinan 61
São Paulo 61
Redondo Beach 52
Helsinki 49
London 49
Shenyang 47
Santa Clara 46
Tokyo 46
Columbus 44
Redmond 42
Buffalo 39
Milan 38
Tianjin 35
Hebei 34
Nanjing 33
Rome 31
Sindelfingen 31
Orem 30
Abuja 27
Seattle 27
Ningbo 26
Montreal 25
Toronto 25
Turku 25
Bologna 24
Changsha 24
Cotonou 24
Chennai 23
Warsaw 23
Redwood City 22
Brussels 21
Lomé 21
Hangzhou 20
Nuremberg 20
Da Nang 19
Frankfurt am Main 19
Rio de Janeiro 19
Guangzhou 18
Zhengzhou 18
Amsterdam 17
Haiphong 17
Lancaster 17
Seoul 17
Taizhou 17
Brooklyn 16
Mexico City 16
Chicago 15
Jakarta 15
Johannesburg 15
Madrid 15
Nanchang 15
Phoenix 15
Atlanta 14
Baghdad 14
Biên Hòa 14
San Francisco 14
Belo Horizonte 13
Boston 13
Denver 13
Stockholm 13
Taiyuan 13
Dearborn 12
Fortaleza 12
Manchester 12
Boardman 11
Guayaquil 11
Fairfield 10
Haikou 10
Norwalk 10
Shanghai 10
Ankara 9
Chongqing 9
Paris 9
Poplar 9
Pozza 9
Totale 8.602
Nome #
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 247
Application of international consensus diagnostic criteria to an Italian series of autoimmune pancreatitis 242
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 241
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 239
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 229
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 219
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 216
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations 215
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 214
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 207
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 200
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 199
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 192
Donor kidneys with miliary papillary renal cell neoplasia: the role of the pathologist in determining suitability for transplantation 191
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 188
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 187
Pancolitis with ischemic injury as a complication of immunosuppressive treatment in a patient with autoimmune hepatitis: a case report. 177
Expression of programmed cell death ligand 1 in non-small cell lung cancer: Comparison between cytologic smears, core biopsies, and whole sections using the SP263 Assay 177
Cathepsin K expression in clear cell "sugar" tumor (PEComa) of the lung 176
A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss 175
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 173
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 172
Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors 172
t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma 167
Increased Frequency of Bronchiolar Histotypes in Lung Carcinomas Associated with Idiopathic Pulmonary Fibrosis 162
Primary Seminal Vesicle Carcinoma. The Usefulness of Pax8 Immunohistochemical Expression for the Differential Diagnosis 161
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center 161
Epithelial to mesenchymal transition-related proteins ZEB1, β-catenin, and β-tubulin-III in idiopathic pulmonary fibrosis 160
2022-RA-1535-ESGO Uterine PEComa and prognostic value of the proposed classification systems: a retrospective study, systematic review, and metanalysis 157
Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned 157
Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation 156
From fine-needle aspiration cytology to fluorescent in-situ hybridization in an unusual case of pharyngeal synovial sarcoma 156
Multifocal Hepatic Angiosarcoma with Atypical Presentation: Case Report and Literature Review 155
Is there a correlation between 3T multiparametric MRI and molecular subtypes of breast cancer? 150
Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection 148
MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge 147
ARID1A mutational status in non-small cell lung cancer: from molecular pathology to clinical implications with a focus on the relationships with EGFR 146
Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification 145
Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis 144
Angiomyolipoma of the kidney: from simple hamartoma to complex tumour 141
Intestinal-type primary vaginal adenocarcinoma. Review of the literature with report of a case: from diagnosis to management 140
Parvalbumin immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 139
Recurrent primary endobronchial fetal rhabdomyoma: a case report and literature review 139
Molecular predictors of EGFR-mutant NSCLC transformation into LCNEC after frontline osimertinib: digging under the surface 138
MiT family translocation renal cell carcinoma: looking for diagnostic and druggable markers 137
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma 136
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 131
Cystic Nephroma in Adults: A Clinicopathologic Study of 46 Cases 129
Histology and immunohistochemical evaluation of phimotic prepuce: The role of steroid therapy 129
Pre-implantation kidney biopsy: value of the expertise in determining histological score and comparison with the whole organ on a series of discarded kidneys 126
Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma 125
Correction to: Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme 125
Artificial Intelligence in Renal Cell Carcinoma Histopathology: Current Applications and Future Perspectives 124
High fidelity of driver chromosomal alterations among primary and metastatic renal cell carcinomas: implications for tumor clonal evolution and treatment 120
A tribute to Prof. Ondrej Hes, MD, PhD (1968-2022) 117
Renomedullary Interstitial Cell Tumors: Pathologic Features and Clinical Correlations 117
TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1 116
TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study 116
Renal cell carcinoma with TFE3 translocation and succinate dehydrogenase B mutation 114
TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms 112
Testicular cancer: The usage of central review for pathology diagnosis of orchiectomy specimens 111
Quantitative score modulation of HSP90 and HSP27 in clear cell renal cell carcinoma 109
Mixed Epithelial and Stromal Tumor of the Kidney: A Clinicopathologic Study of 53 Cases 109
Exceptional Response in BRAF p.V600E-Mutant Enteric-Type Adenocarcinoma of the Lung With Cutaneous Spread: A Case Report 107
Robot-assisted excision of hemangioma of the right renal vein 105
♂♀ Mixed Epithelial and Stromal Tumors of the Kidney 104
Interobserver Agreement in Immunohistochemical Evaluation of Folate Receptor Alpha (FRα) in Ovarian Cancer: A Multicentre Study 102
Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme 102
Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey 102
Small renal masses in young adults: Insights from a large contemporary multi-institutional Registry 101
VEGFA amplification/increased gene copy number and VEGFA mRNA expression in renal cell carcinoma with TFEB gene alterations 101
STING is a prognostic factor related to tumor necrosis, sarcomatoid dedifferentiation, and distant metastasis in clear cell renal cell carcinoma 100
Well-differentiated neuroendocrine tumor of the urinary bladder expressing GATA 3 99
Immune checkpoint inhibitors for non-small-cell lung cancer: does that represent a 'new frontier'? 99
Stimulator of interferon genes (STING) immunohistochemical expression in fumarate hydratase-deficient renal cell carcinoma: biological and potential predictive implications 98
HER2 Aberrations in NSCLC: So Close Yet So Far 98
Reply to Chou et al 'Do significant TFE3 gene rearrangements occur in succinate dehydrogenase deficient renal cell carcinoma? Borderline FISH results should be interpreted with caution' Mod Pathol 2017; in press 96
Papillary Adenomas and Other Small Epithelial Tumors in the Kidney: An Autopsy Study 96
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 96
Epithelioid angiomyolipoma: a pathological entity discovered in Verona with the endorsement of Doctor Rosai 95
Determinants of oncologic outcomes in high-grade organ-confined prostate cancer after prostatectomy 94
Uterine perivascular epithelioid cell tumors (PEComa) and the accuracy of proposed classification systems in predicting the malignant versus non-malignant behavior 91
Patient Selection for Active Surveillance for Small Renal Masses: A Systematic Review of the Literature 90
Diagnostic utility of one-stop fusion gene panel to detect TFE3/TFEB gene rearrangement and amplification in renal cell carcinomas 90
Predicting progression in T1 non-muscle-invasive bladder cancer: back to histology 88
Pathological features and clinical associations of 58 small incidental angiomyolipomas of the kidney. 88
Identification of diagnostic and predictive morphological and molecular markers in renal tumors 86
Stimulator of interferon genes (STING) immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 85
Hot topics in renal cancer pathology: implications for clinical management 84
SFPQ::TFE3-rearranged PEComa: Differences and analogies with renal cell carcinoma carrying the same translocation 82
A modified Delphi consensus statement on the role of biopsy in small renal masses 81
HER2-Driven Breast Cancer: Role of the Chaperonin HSP90 in Modulating Response to Trastuzumab-Based Therapeutic Combinations 79
The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data 78
Interleukin-8 as a potential prognostic biomarker in Renal Cell Carcinoma: A systematic review and Meta-Analysis 76
The expanding role of next-generation imaging in prostate cancer management: a cross-sectional survey exploring the clinical practice of uro-oncologists in North-Eastern Italy; on behalf of GUONE (Gruppo Uro-Oncologico del Nord-Est) 75
Histology for nephrology, from pre-implantation to post-transplant kidney biopsy. Lesson learned from ReBIrth (Renal BIopsy for Kidney Transplantation Therapy) 74
WHO 2022 Classification of Kidney Tumors: what is relevant? An update and future novelties for the pathologist 73
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma 72
TFE3-Rearranged Tumors of the Kidney: An Emerging Conundrum 70
The World Health Organization 2022 Classification of renal tumors: key updates for urologists 69
Totale 13.446
Categoria #
all - tutte 47.697
article - articoli 45.752
book - libri 0
conference - conferenze 1.020
curatela - curatele 0
other - altro 582
patent - brevetti 0
selected - selezionate 0
volume - volumi 343
Totale 95.394


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021134 0 0 0 0 0 0 0 0 0 31 67 36
2021/2022598 65 151 3 69 29 26 17 37 20 14 42 125
2022/20231.260 80 134 105 220 99 330 19 65 130 21 33 24
2023/2024786 35 55 73 73 88 127 42 54 22 48 122 47
2024/20252.415 124 136 185 319 93 76 128 96 313 231 268 446
2025/20267.444 508 451 724 1.223 1.826 473 695 448 644 452 0 0
Totale 14.638